What to Learn from a Comparative Genomic Sequence Analysis of L-Carnitine Dehydrogenase

In contrast to eukaryotic cells certain eubacterial strains have acquired the ability to utilize L-carnitine (R-(–)-3-hydroxy-4-(trimethylamino)butyrate) as sole source of energy, carbon and nitrogen. The first step of the L-carnitine degradation to glycine betaine is catalysed by L-carnitine dehydrogenase (L-CDH, EC 1.1.1.108) and results in the formation of the dehydrocarnitine. During the oxidation of L-carnitine a simultaneous conversion of the cofactor NAD⁺ to NADH takes place. This catabolic reaction has always been of keen interest, because it can be exploited for spectroscopic L-carnitine determination in biological fluids – a quantification method, which is developed in our lab – as well as L-carnitine production.Based on a cloned L-CDH sequence an expedition through the currently available prokaryotic genomic sequence space began to mine relevant information about bacterial L-carnitine metabolism hidden in the enormous amount of data stored in public sequence databases. Thus by means of homology-based and context-based protein function prediction is revealed that L-CDH exists in certain eubacterial genomes either as a protein of approximately 35 kDa or as a homologous fusion protein of approximately 54 kDa with an additional putative domain, which is predicted to possess a thioesterase activity. These two variants of the enzyme are found on one hand in the genome sequence of bacterial species, which were previously reported to decompose L-carnitine, and on the other hand in gram-positive bacteria, which were not known to express L-CDH. Furthermore we could not only discover that L-CDH is located in a conserved genetic entity, which genes are very likely involved in this L-carnitine catabolic pathway, but also pinpoint the exact genomic sequence position of several other enzymes, which play an essential role in the bacterial metabolism of L-carnitine precursors.     

Effects of <Emphasis Type="Italic">L</Emphasis>-Carnitine Supplementation in Sows

Summary. In recent years L-carnitine has been used increasingly in animals. This review gives an overview of the effects of dietary L-carnitine supplementation during pregnancy and lactation on the reproductive performance of sows. In one investigation L-carnitine supplementation during pregnancy increased the number of piglets born to sows. Other studies showed heavier litters in sows supplemented with L-carnitine compared with control sows, and litters of L-carnitine supplemented sows gained more weight during the suckling period than litters of control sows. This effect might be due to more vigorous suckling by piglets of L-carnitine supplemented sows, causing the sows’ milk production to rise. At negative energy balance during lactation L-carnitine supplemented sows are able to mobilize more energy from adipose tissue, which can be used for the production of surplus milk. In conclusion, recent studies clearly show that dietary L-carnitine supplementation increases the reproductive performance of sows. This finding suggests that the amount of L-carnitine synthesized endogenously does not cover the requirement for maximum sow performance during pregnancy and lactation.     

Protective Effects of <Emphasis Type="Italic">L</Emphasis>-Carnitine on Myocardium of Experimentally Diabetic Rats with Additional Ischaemia and Reperfusion

Summary. We investigated the protective effects of L-carnitine against damage to the heart caused by diabetes-induced alterations and additional ischaemia and reperfusion in diabetic BB/OK rats using histological techniques, morphometry, biochemical parameters of oxidative stress, and SOD expression. The results revealed that diabetes-induced morphological changes were partly improved or nearly prevented by substitution of L-carnitine, which also seemed to improve the reduced tolerance of diabetic myocardium towards ischaemia/reperfusion with respect to morphological parameters. Immunohistochemical and biochemical parameters of oxidative stress such as SOD protein expression as well as SOD and GPx activity indicate increased free oxygen radical level in the ischaemic/reperfused diabetic myocardium, which is clearly decreased by L-carnitine treatment. We suggest that L-carnitine may be an adequate “causal” agent in the protection of myocardial alterations in diabetes with additional ischaemia and reperfusion, as it stabilizes mitochondrial and cellular function and acts through its antioxidative or radical scavenging potential. Further investigations are necessary to determine an approach towards adjuvant treatment of diabetic myocardial complications using L-carnitine.     

Effects of <Emphasis Type="Italic">L</Emphasis>-Carnitine on Sucrose-Induced Hyperlipidaemia

Summary. L-Carnitine, L-(−)-β-hydroxy-γ-trimethylaminobutyrate, plays an important role as a factor necessary for the transport of long-chain fatty acids into the mitochondria. In order to investigate the influence of L-carnitine on hyperlipidaemias, the experimental model of the sucrose-induced hypertriglyceridaemia of the rat was used. In these experiments L-carnitine in the dose of 11 mg per day and 100 g body weight (over the period of 1 week) was able to antagonize the sucrose-induced hypertriglyceridaemia and the increase of serum free fatty acid level in female rats of the Wistar strain. Carnitine administration did not change the activities of lipogenic enzymes and fatty acid synthesis in the liver. However, L-carnitine increases the rate of hepatic fatty acid oxidation. Our results indicate a hypotriglyceridemic and free fatty acid lowering effect of L-carnitine, and suggest the use of this compound in the therapy of hyperlipidaemias.     

Oral <Emphasis Type="Italic">L</Emphasis>-Carnitine Supplementation and Exercise Metabolism

Summary. Oral L-carnitine supplementation is frequently reported to have beneficial effects on exercise capacity in clinical populations and has been considered as a potential ergogenic aid for endurance athletes. However, this latter view is largely unsubstantiated possibly due to many experimental studies being poorly controlled or difficult to compare. The potential for oral L-carnitine supplementation to influence skeletal muscle carnitine content has been questioned and there are several key factors identified that may explain variations between study outcomes. Recent more well controlled research suggests some potential for L-carnitine to act as a key regulator of cellular stress, possibly through an impact on the integration of carbohydrate and lipid metabolism, and this work should be followed up in future by well controlled studies in both athlete and clinical subject groups.     

Large Scale Bioprocess for the Production of Optically Pure <Emphasis Type="Italic">L</Emphasis>-Carnitine

Summary. A competitive production method using the biotransformation of 4-butyrobetaine to enantiomerically pure L-carnitine was developed and scaled-up by Lonza. The process produces L-carnitine in 99.5% yield, and >99.9% enantiomeric excess (ee). Continuous and discontinuous processes were developed but the fed-batch process was found to be economically the most favourable process mode.     

Current Methods for Determination of <Emphasis Type="Italic">L</Emphasis>-Carnitine and Acylcarnitines

Summary. L-Carnitine as endogenous compound plays an important role within several metabolic pathways and a deficiency of L-carnitine can cause adverse effects in physiological and/or mental state of health and disease. The prevention of diseases related to carnitine deficiency requires, first of all, the exact determination of L-carnitine and its esters in biological material at pmol/cm³ level. A series of analytical procedures based on biochemical assays as well as on physical methods are available today. Determination of free and total carnitine is sometimes sufficient for a clinical diagnosis, but in most cases, such as in newborn screening for genetic disorders, detailed qualitative and quantitative L-carnitine/acylcarnitine profiling is needed. Technological progress has also revolutionized the determination of carnitines. Today, comprehensive and diagnostically relevant information can be obtained by mass spectrometry. An overview is given of the technical and methodological developments in carnitine analysis and some applications, such as in neonatal screening, diabetes mellitus, and cardiomyopathy.     

Effects of L-Carnitine on Sucrose-Induced Hyperlipidaemia

L-Carnitine, L-(−)-β-hydroxy-γ-trimethylaminobutyrate, plays an important role as a factor necessary for the transport of long-chain fatty acids into the mitochondria. In order to investigate the influence of L-carnitine on hyperlipidaemias, the experimental model of the sucrose-induced hypertriglyceridaemia of the rat was used. In these experiments L-carnitine in the dose of 11 mg per day and 100 g body weight (over the period of 1 week) was able to antagonize the sucrose-induced hypertriglyceridaemia and the increase of serum free fatty acid level in female rats of the Wistar strain. Carnitine administration did not change the activities of lipogenic enzymes and fatty acid synthesis in the liver. However, L-carnitine increases the rate of hepatic fatty acid oxidation. Our results indicate a hypotriglyceridemic and free fatty acid lowering effect of L-carnitine, and suggest the use of this compound in the therapy of hyperlipidaemias.     

Effects of L-Carnitine and its Derivatives – Studies on Isolated Hearts

Summary. The metabolism in the heart prefers long-chain fatty acids to other substrates. L-Carnitine, a co-factor of coenzyme A, plays an essential role in the transport of long-chain fatty acids through the inner mitochondrial membrane. Without carnitine, metabolisation of long-chain fatty acids in the mitochondria is not possible. In addition, acyl groups from acyl-CoA compounds can be transferred to L-carnitine, thus influencing the enzymatic activities of important mitochondrial enzymes.The isolated heart model developed by Langendorff was used to investigate the effects of L-carnitine on the heart. During aerobic perfusion, the hemodynamic parameters of isolated hearts reacted in a very sensitive way to alterations in the external conditions (temperature, preload, composition of the perfusion solution). During postischemic perfusion, recovery of the hearts was also influenced by the composition of the perfusion. The hemodynamic parameters of the reperfused hearts increased markedly if there was a sufficiently high supply of long-chain fatty acids and/or glucose. The insufficient recovery of hearts perfused without glucose and at low fatty acid concentrations could be improved by adding L-carnitine. Determination of carnitine levels in heart tissue found that the heart loses about 30% of its carnitine content during ischemia, and that exogenous carnitine is taken up by the heart during reperfusion. There it effects the restoration of sufficient concentrations of creatine phosphate and ATP, a fact that was confirmed by ³¹P NMR spectroscopy. NMR spectroscopy also established that L-carnitine lessens the harmful effects of ischemia-induced metabolic acidosis.The favourable influence of L-carnitine on the heart in the reperfusion period could be due to a reduction in oxygen radicals (lowering of MDA concentrations during reperfusion, raising of GP_x and SOD activities).The findings of these experiments on isolated hearts as well as the favourable results of two placebo-controlled and double-blind clinical studies (investigating the effects of carnitine in cardiomyopathy patients and the effects of L-carnitine in hemodialysis patients) demonstrate that L-carnitine produces positive therapeutic effects, particularly in heart and circulatory diseases.     

<Emphasis Type="Italic">L</Emphasis>-Carnitine Supplementation: A New Paradigm for its Role in Exercise

Summary. Early research investigating the effects of L-carnitine supplementation has examined its role in substrate metabolism and in acute exercise performance. These studies have yielded equivocal findings, partially due to difficulties in increasing muscle carnitine concentrations. However, recent studies have proposed that L-carnitine may play a different role in exercise physiology, and preliminary results have been encouraging. Current investigations have theorized that L-carnitine supplementation facilitates exercise recovery. Proposed mechanism is as follows: 1) increased serum carnitine concentration enhances capillary endothelial function; 2) increased blood flow and reduced hypoxia mitigate the cascade of ensuing, destructive chemical events following exercise; 3) thus allowing reduced structural damage of skeletal muscle mediated by more intact receptors in muscle needed for improved protein signaling. This paradigm explains decreased markers of purine catabolism, free radical formation, and muscle tissue disruption after resistance exercise and the increased repair of muscle proteins following long-term L-carnitine supplementation.     

Protective Effects of L-Carnitine on Myocardium of Experimentally Diabetic Rats with Additional Ischaemia and Reperfusion

We investigated the protective effects of L-carnitine against damage to the heart caused by diabetes-induced alterations and additional ischaemia and reperfusion in diabetic BB/OK rats using histological techniques, morphometry, biochemical parameters of oxidative stress, and SOD expression. The results revealed that diabetes-induced morphological changes were partly improved or nearly prevented by substitution of L-carnitine, which also seemed to improve the reduced tolerance of diabetic myocardium towards ischaemia/reperfusion with respect to morphological parameters. Immunohistochemical and biochemical parameters of oxidative stress such as SOD protein expression as well as SOD and GPx activity indicate increased free oxygen radical level in the ischaemic/reperfused diabetic myocardium, which is clearly decreased by L-carnitine treatment. We suggest that L-carnitine may be an adequate “causal” agent in the protection of myocardial alterations in diabetes with additional ischaemia and reperfusion, as it stabilizes mitochondrial and cellular function and acts through its antioxidative or radical scavenging potential. Further investigations are necessary to determine an approach towards adjuvant treatment of diabetic myocardial complications using L-carnitine.     

Fabrication of a novel Li<Subscript><Emphasis Type="Italic">x</Emphasis></Subscript>MoO<Subscript><Emphasis Type="Italic">y</Emphasis></Subscript> film modified electrode and its application as an electrochemical sensor of iodate

A novel organic gel film modified electrode was simply and conveniently fabricated by casting Li_xMoO_y and polypropylene carbonate (PPC) onto the surface of a gold electrode. The cyclic voltammetry and amperometry studies demonstrated that the Li_xMoO_y film modified electrode has a high stability and a good electrocatalytic activity for the reduction of iodate. In amperometry, a good linear relationship between the steady current and the concentration of iodate was obtained in the range from 3×10^–7 to 1×10^–4 mol L^–1 with a correlation coefficient of 0.9997 and a detection limit of 1×10^–7 mol L^–1.     

Crystal structure and IR spectrum of 1-O-α- -glucopyranosyl- -mannitol–ethanol (2/1)

1-O-α- -Glucopyranosyl- -mannitol–ethanol (2/1), (C₁₂H₂₄O₁₁)₂–C₂H₅OH, crystallizes in the monoclinic space group P2₁ with unit cell dimensions a=11.4230(8) Å, b=9.525(4) Å, c=15.854(2) Å, β=102.751(7)° and V=1682.4(7) ų, Z=2, D_x=1.45 Mg m⁻³, λ (Mo-K_α)=0.71069 Å, μ=0.128 mm⁻¹, F(000)=788 and T=293(2) K. The structure was solved by direct methods and refined by least-squares calculations on F² to R₁=0.0371[I>2σ(I)], and 0.0930 (all data, 3542 independent reflections, R_int=0.021). There are two molecules of glucopyranosylmannitol (GPM) and one ethanol molecule in the asymmetric unit, and the glucopyranosyl ring adopts a chair conformation in both GPM molecules. Bond lengths and angles accord well with the mean values of related structures. The conformation along the mannitol side chain for one of the GPM molecules was the same as for the known polymorphs of -mannitol, while the conformation of the other molecule was different, indicating different conformational arrangements in the terminal carbon atoms of the mannitol side chains of the two GPM molecules. The structure in 1-O-α- -glucopyranosyl- -mannitol–ethanol (2/1) is held together by a very complex hydrogen bonding system, which consists of an infinte chain propagating along the b-axis and a discontinuous chain, which binds the ethanol molecule to the structure. The FTIR spectra for anhydrous GPM, GPM dihydrate and GPM–ethanol (2/1) were recorded. Both IR and X-ray results indicate the extensive hydrogen bonding in crystalline state.     

Use of ICP and XAS to determine the enhancement of gold phytoextraction by <Emphasis Type="Italic">Chilopsis linearis</Emphasis> using thiocyanate as a complexing agent

Under natural conditions gold has low solubility that reduces its bioavailability, a critical factor for phytoextraction. Researchers have found that phytoextraction can be improved by using synthetic chelating agents. Preliminary studies have shown that desert willow (Chilopsis linearis), a common inhabitant of the Chihuahuan Desert, is able to extract gold from a gold-enriched medium. The objective of the present study was to determine the ability of thiocyanate to enhance the gold-uptake capacity of C. linearis. Seedlings of this plant were exposed to the following hydroponics treatment: (1) 5 mg Au L^–1 (2.5×10^–5 mol L^–1), (2) 5 mg Au L^–1+10^–5 mol L^–1 NH₄SCN, (3) 5 mg Au L^–1+5×10^–5 mol L^–1 NH₄SCN, and (4) 5 mg Au L^–1+10^–4 mol L^–1 NH₄SCN. Each treatment had its respective control. After 2 weeks we determined the effect of the treatment on plant growth and gold content by inductively coupled plasma–optical emission spectroscopy (ICP–OES). No signs of shoot-growth inhibition were observed at any NH₄SCN treatment level. The ICP–OES analysis showed that addition of 10^–4 mol L^–1 NH₄SCN increased the concentration of gold by about 595, 396, and 467% in roots, stems, and leaves, respectively. X-ray absorption spectroscopy (XAS) studies showed that the oxidation state of gold was Au(0) and that gold nanoparticles were formed inside the plants.     

Effects of L-Carnitine Supplementation in Sows

In recent years L-carnitine has been used increasingly in animals. This review gives an overview of the effects of dietary L-carnitine supplementation during pregnancy and lactation on the reproductive performance of sows. In one investigation L-carnitine supplementation during pregnancy increased the number of piglets born to sows. Other studies showed heavier litters in sows supplemented with L-carnitine compared with control sows, and litters of L-carnitine supplemented sows gained more weight during the suckling period than litters of control sows. This effect might be due to more vigorous suckling by piglets of L-carnitine supplemented sows, causing the sows’ milk production to rise. At negative energy balance during lactation L-carnitine supplemented sows are able to mobilize more energy from adipose tissue, which can be used for the production of surplus milk. In conclusion, recent studies clearly show that dietary L-carnitine supplementation increases the reproductive performance of sows. This finding suggests that the amount of L-carnitine synthesized endogenously does not cover the requirement for maximum sow performance during pregnancy and lactation.     

Investigation of 2-[(<Emphasis Type="Italic">E</Emphasis>)-2-(4-diethylaminophenyl)-1-ethenyl]-1,3,3-trimethyl-3H-indolium as a new highly sensitive reagent for the spectrophotometric determination of nitrophenols

A new, simple, rapid, and sensitive spectrophotometric method has been developed for the determination of nitrophenols [picric acid (PA); dinitrophenols (DNP)] in wastewater samples. The method is based on the reaction of nitrophenols with 2-[(E)-2-(4-diethylaminophenyl)-1-ethenyl]-1,3,3-trimethyl-3 H-indolium chloride reagent to form the colored ion associates, which are extracted by organic solvents. The molar absorptivity of the ion associates of PA with the investigated reagent ranges from 8.3×10⁴ to 11.3×10⁴ L mol^–1 cm^–1, depending on the extractant. Because only PA is extracted in an acidic medium with the investigated reagent, but both PA and DNP are extracted in an alkaline medium, it is possible to determine both substances in a mixture. Appropriate reaction conditions have been established. The absorbance of the colored extracts obeys Beers law in the range of 0.04–4.58 mg L^–1 PA, 1.0–18.4 mg L^–1 2,4-DNP and 1.2–14.7 mg L^–1 2,6-DNP, respectively. The limit of detections, calculated from a blank test (n=10; P=0.95), are 0.05 mg L^–1 PA, 0.9 mg L^–1 (2,4-DNP), and 1.1 mg L^–1 (2,6-DNP), respectively.     

Preparation of new dinuclear half-titanocene complexes with ortho- and meta-xylene linkages and investigation of styrene polymerization

Half-titanocene is well-known as an excellent catalyst for the preparation of SPS (syndiotactic polystyrene) when activated with methylaluminoxane (MAO). Dinuclear half-sandwich complexes of titanium bearing a xylene bridge, (TiCl₂L)₂{(μ-η⁵, η⁵-C₅H₄-ortho-(CH₂–C₆H₄–CH₂)C₅H₄}, (4 (L = Cl), 7 (L = O-2,6-iPr₂C₆H₃)) and (TiCl₂L)₂{(μ-η⁵, η⁵-C₅H₄-meta-(CH₂–C₆H₄–CH₂)C₅H₄} (5 (L = Cl), 8(L = O-2,6-iPr₂C₆H₃)), have been successfully synthesized and introduced for styrene polymerization. The catalysts were characterized by ¹H- and ¹³C NMR, and elemental analysis. These catalysts were found to be effective in forming SPS in combination with MAO. The activities of the catalysts with rigid ortho- and meta-xylene bridges were higher than those of catalysts with flexible pentamethylene bridges. The catalytic activity of four dinuclear half-titanocenes increased in the order of 4 < 5 < 7 < 8. This result displays that the meta-xylene bridged catalyst is more active than the ortho-xylene bridged and that the aryloxo group at the titanium center is more effective at promoting catalyst activity compared to the chloride group at the titanium center. Temperature and ratio of [Al]:[Ti] had significant effects on catalytic activity. Polymerizations were conducted at three different temperatures (25, 40, and 70 °C) with variation in the [Al]:[Ti] ratio from 2000 to 4000. It was observed that activity of the catalysts increased with increasing temperature, as well as higher [Al]:[Ti]. Different xylene linkage patterns (ortho and meta) were recognized to be a principal factor leading to the characteristics of the dinuclear catalyst due to its different spatial arrangement, causing dissimilar intramolecular interactions between the two active sites.     

Lithiated γ-O-functionalized propyl phenyl sulfides and sulfones of the type Li[CH(SOxPh)CH2CH2OR] (x = 0, 2). [Li{CH(SPh)CH2CH2Ot-Bu}(tmeda)] – A structurally characterized organolithium inner complex

Lithiation of O-functionalized alkyl phenyl sulfides PhSCH₂CH₂CH₂OR (R = Me, 1a; i-Pr, 1b; t-Bu, 1c; CPh₃, 1d) with n-BuLi/tmeda in n-pentane resulted in the formation of α- and ortho-lithiated compounds [Li{CH(SPh)CH₂CH₂OR}(tmeda)] (α-2a–d) and [Li{o-C₆H₄SCH₂CH₂CH₂OR)(tmeda)] (o-2a–d), respectively, which has been proved by subsequent reaction with n-Bu₃SnCl yielding the requisite stannylated γ-OR-functionalized propyl phenyl sulfides n-Bu₃SnCH(SPh)CH₂CH₂OR (α-3a–d) and n-Bu₃Sn(o-C₆H₄SCH₂CH₂CH₂OR) (o-3a–d). The α/ortho ratios were found to be dependent on the sterical demand of the substituent R. Stannylated alkyl phenyl sulfides α-3a–c were found to react with n-BuLi/tmeda and n-BuLi yielding the pure α-lithiated compounds α-2a–c and [Li{CH(SPh)CH₂CH₂OR}] (α-4a–b), respectively, as white to yellowish powders. Single-crystal X-ray diffraction analysis of [Li{CH(SPh)CH₂CH₂Ot-Bu}(tmeda)] (α-2c) exhibited a distorted tetrahedral coordination of lithium having a chelating tmeda ligand and a C,O coordinated organyl ligand. Thus, α-2c is a typical organolithium inner complex.Lithiation of O-functionalized alkyl phenyl sulfones PhSO₂CH₂CH₂CH₂OR (R = Me, 5a; i-Pr, 5b; CPh₃, 5c) with n-BuLi resulted in the exclusive formation of the α-lithiated products Li[CH(SO₂Ph)CH₂CH₂OR] (6a–c) that were found to react with n-Bu₃SnCl yielding the requisite α-stannylated compounds n-Bu₃SnCH(SO₂Ph)CH₂CH₂OR (7a–c). The identities of all lithium and tin compounds have been unambiguously proved by NMR spectroscopy (¹H, ¹³C, ¹¹⁹Sn).     

Synthesis, reactions and X-ray crystal structures of metallacrown ethers with unsymmetrical bis(phosphinite) and bis(phosphite) ligands derived from 2-hydroxy-2′-(1,4-bisoxo-6-hexanol)-1,1′-biphenyl

Chlorodiphenylphosphine and 2,2′-biphenylylenephosphorochloridite react with 2-hydroxy-2′-(1,4-bisoxo-6-hexanol)-1,1′-biphenyl to yield the new α,ω-bis(phosphorus-donor)-polyether ligands, 2-Ph₂PO(CH₂CH₂O)₂–C₁₂H₈-2′-OPPh₂ (1) and 2-(2,2′-O₂C₁₂H₈)P(CH₂CH₂O)₂–C₁₂H₈-2′-P(2,2′-O₂C₁₂H₈) (2). These ligands react with Mo(CO)₄(nbd) to form the monomeric metallacrown ethers, cis-Mo(CO)₄{2-Ph₂PO(CH₂CH₂O)₂–C₁₂H₈-2′-OPPh₂} (cis-3) and cis-Mo(CO)₄{2-(2,2′-O₂C₁₂H₈)P(CH₂CH₂O)₂–C₁₂H₈-2′-P(2,2′-O₂C₁₂H₈)} (cis-4), in good yields. The X-ray crystal structures of cis-3 and cis-4 are significantly different, especially in the conformation of the metal center and the adjacent ethylene group. The very different ¹³C-NMR coordination chemical shifts of this ethylene group in cis-3 and cis-4 suggest that the solution conformations of these metallacrown ethers are also quite different. Both metallacrown ethers undergo cis–trans isomerization in the presence of HgCl₂. Although the cis–trans equilibrium constants for the isomerization reactions are nearly identical, the isomerization of cis-3 is more rapid. Phenyl lithium reacts with cis-3 to form the corresponding benzoyl complexes but does not react with either trans-3 or cis-4. Both the slower rate of cis–trans isomerization of cis-4 and its lack of reaction with PhLi are consistent with weaker interactions between the hard metal cations and the carbonyl oxygens in both trans-3 and cis-4.     

Carnitine in Pregnancy

Summary. By the 12^th week of gestation, mean whole blood and plasma carnitine levels are already significantly (p<0.01) lower than those of controls, with a further significant (p<0.01) decrease up to parturition. Diminished carnitine levels may cause a downregulation of carnitine palmitoyltransferase1 (CPT1), both the liver isoform (CPT1A) and muscle isoform (CPT1B), carnitine palmitoyltransferase2 (CPT2), and carnitine acetyltransferase (CRAT) in white blood cells of pregnant women, as determined by real time PCR using the LightCyclerSYBR Green technology.L-Carnitine-L-tartrate supplementation of 2 g/d resulted in an up to 10-fold increase of the relative mRNA abundances of CPT1B, CPT2, and OCTN2 and a 5-fold increase of CPT1A, and CRAT.There is a relationship between the relative mRNA levels of CPT1A and CPT1B and the FFA plasma levels. The substitution of 2 g L-carnitine-L-tartrate/d resulted in significant (p<0.001) lower FFA levels compared to untreated controls and the groups substituted with 0.5 and 1 g L-carnitine/d although plasma carnitine levels were not significantly increased. The most substantial effect was the reduced portion of acylcarnitines on total carnitine in those women receiving 2 g L-carnitine-L-tartrate.Carnitine substitution resulted in an enhanced excretion of both, free carnitine and acylcarnitines, whereas acetylcarnitine accounts for 50–65% of total acylcarnitines.The results of the present study provide evidence that L-carnitine supplementation in pregnancy in sufficient doses avoids a striking increase of plasma FFAs, which are thought to be the main cause of insulin resistance and consequently gestational diabetes mellitus (GDM).